Back to Search

MLYS

Mineralys Therapeutics, Inc. Common Stock
Data: 2026-09-11
$28.2
Price
-3.75%
Change
$47.65
52W High
$22.30
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Sep 11, 2026

33.3

AI Score

EXTENDED

1.86

Volume Ratio

TBA

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

MLYS Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

MLYS Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

MLYS Options - Sort by Max open Interest (near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

MLYS Daily Out of Money Options - Sort by Max open Interest (near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

MLYS Daily In the Money Options - Sort by Max open Interest (near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

MLYS Most Active Options by Volume(near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track
MLYS Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

MLYS Stock Summary

Last updated Sep 11, 2026

MLYS is currently trading at $28.2, positioned below its 200-day moving average of $29.37, suggesting bearish momentum. The stock has a 52-week range of $22.3 to $47.65.

Technical Analysis: The 50-day moving average stands at $27.23, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 53.561, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.015, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates MLYS at 33.3/100 with a EXTENDED recommendation.

MLYS (Mineralys Therapeutics, Inc. Common Stock) Indicators

Last updated Sep 11, 2026

Indicator Value
RSI(14) 53.561
CMF (20) -0.015
ROC (10) 8.42
ADX (14) 20.176
Indicator Value
MACD (12,26,9) 0.767
AROONOSC (14) 78.571
WILLAMS %R (14) -53.835
MFI (14) 62.418

MLYS Candlestick Patterns

No validated candlestick patterns fired for MLYS in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.

Mineralys Therapeutics, Inc. Common Stock is above the 50 Day SMA but below the 200 Day SMA — short-term strength within a longer-term downtrend (Mixed).

MLYS Moving Averages Analysis

Mineralys Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 11, 2026

MLYS (Mineralys Therapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Sep 11, 2026

Days MA
10 28.15
20 27.08
30 26.95
50 27.23
100 27.22
200 29.37

MLYS Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 2.6 billion
Earnings/Share ($) -4.2
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -4.4286
EPS Estimate Next Year ($) -2.5
WallStreet Target Price ($) 48.50
Most Recent Quarter

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.